SIPAI HEALTH (00314) purchased 1,239,000 shares for 3.5034 million Hong Kong dollars on January 14th.
Sino Plus Health (00314) announced that on January 14, 2026, the company spent HK$3.5034 million to repurchase 123.9 million shares of the company at a repurchase price of HK$2.71-2.89 per share; and issued 11,600 shares of the company based on the revised and restated 2017 Global Share Plan exercising options.
SIPAI HEALTH (00314) announced that on January 14, 2026, the company will spend HKD 3.5034 million to repurchase 123.9 million shares, with a repurchase price of HKD 2.71-2.89 per share; 11,600 shares will be issued based on the revised and restated 2017 global stock plan exercise options.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


